Acadia Pharma’s stock falls 15% after failed drug trial

March 12, 2024

78

Must read

admin https://manualproofer.com

One of Acadia Pharma’s drugs failed to meet goals of a late-stage trial about a schizophrenia treatment.

Source link

Previous article

The COVID Catapult: Four Trends Upending the Status Quo for Women

Next article

Peek Inside the 2024 Academy Awards, Oscar’s VIP Gift Bags

More articles

LEAVE A REPLY Cancel reply

Please enter your comment!

Please enter your name here

You have entered an incorrect email address!

Please enter your email address here

Latest article